- The COVID-19 pandemic has struggled due to a lack of effective antiviral treatments for SARS-CoV-2, highlighting the need for better therapeutic options.
- Previous reliance on vaccines alone hasn't been sufficient, partly because of the virus's rapid evolution, leading researchers to explore drug repurposing as a promising strategy.
- This study reports positive results from a multidrug therapy approach using combinations like hydroxychloroquine and azithromycin, which could help reduce drug resistance and offer new treatment avenues for COVID-19.